Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Medtronic
Boehringer Ingelheim
McKinsey
Johnson and Johnson

Last Updated: August 15, 2022

Drugs in MeSH Category Phosphodiesterase Inhibitors


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Murty Pharms DIPYRIDAMOLE dipyridamole TABLET;ORAL 040733-002 Feb 13, 2007 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
B Braun THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019826-005 Aug 14, 1992 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Impax Labs AMINOPHYLLINE aminophylline TABLET;ORAL 084574-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Teva NEOTHYLLINE dyphylline INJECTABLE;INJECTION 009088-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Inwood Labs THEOPHYLLINE theophylline CAPSULE, EXTENDED RELEASE;ORAL 040052-001 Feb 14, 1994 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Impax Labs PENTOXIFYLLINE pentoxifylline TABLET, EXTENDED RELEASE;ORAL 075093-001 Aug 10, 1999 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Impax Labs DIPYRIDAMOLE dipyridamole TABLET;ORAL 040782-003 Jul 18, 2007 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Boehringer Ingelheim
Colorcon
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.